---
title: "Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) — Share Price, Financials & Analysis"
symbol: "AAREYDRUGS"
company: "Aarey Drugs & Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/AAREYDRUGS"
isin: "INE198H01019"
nse_symbol: "AAREYDRUGS"
bse_code: "524412"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 272.54
generated_at: "2026-09-13T19:32:15.633Z"
---

# Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Canonical page: https://tapetide.com/stocks/AAREYDRUGS

## Company

- **NSE Symbol:** AAREYDRUGS
- **BSE Code:** 524412
- **ISIN:** INE198H01019
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2021-08-06
- **CEO:** Mr. Mihir Rajesh Ghatalia B.E
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** aareydrugs.com

## About

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of  API / Bulk Drugs and offers products for diverse 
industrial applications[1]

## Latest Price

- **Price:** ₹98.89
- **Change:** +3.18 (+3.32%)
- **Open:** ₹95.71
- **Day High:** ₹100.3
- **Day Low:** ₹94.92
- **Previous Close:** ₹95.71
- **Volume:** 369808
- **As Of:** 2026-09-11T10:01:40+00:00

## Key Fundamentals

Observed at 2026-09-11T04:38:17.014734Z.

- **Market Cap:** ₹272.54 Cr
- **Classification:** Microcap
- **P/E (reported):** 70.7
- **P/E (TTM):** 67.27
- **EPS (TTM):** ₹1.47
- **Book Value:** ₹53.9
- **Price to Book:** 1.77
- **Dividend Yield:** 0%
- **ROE:** 2.91%
- **ROCE:** 7.61%
- **Debt to Equity:** 0.33
- **Revenue (yearly):** ₹472.27 Cr
- **Net Income:** ₹3.82 Cr
- **EBITDA:** ₹7.17 Cr
- **52-Week High:** ₹101.29
- **52-Week Low:** ₹50.31
- **RSI (14):** 63.12

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 37.09 | 9% |
| growth | 26.66 | 9% |
| momentum | 91.67 | 12% |
| ownership | 56.42 | 24% |
| quality | 58.12 | 22% |
| valuation | 30.03 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Promoter holding has increased by 5.08% over last quarter.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.27% over past five years.
- Company has a low return on equity of 3.13% over last 3 years.
- Earnings include an other income of Rs.6.26 Cr.
- Promoter holding has decreased over last 3 years: -7.25%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 444.48% | 904.69% | 87.96% |
| ebitda margin growth | -23.08% | -42.97% | -47.18% | -47.18% |
| net income growth | -37.5% | -4.5% | 2% | -9% |
| revenue growth | -75.5% | -2.38% | 4% | 6% |
| roce | — | 7.03% | 5.55% | 8.53% |
| roe | — | -17.56% | 3.22% | -55.84% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 57.83 | 76.48 | 210.35 | 126.91 | 105.14 | 133.79 | 108.1 | 102.21 | 84.16 | 96.43 | 189.47 | 44.63 |
| Expenses | 55.99 | 73.78 | 211.79 | 125.73 | 101.42 | 131.59 | 112.31 | 100.5 | 81.52 | 97.94 | 185.13 | 43.31 |
| Operating Profit | 1.84 | 2.7 | -1.44 | 1.18 | 3.72 | 2.2 | -4.21 | 1.71 | 2.64 | -1.51 | 4.34 | 1.32 |
| OPM % | 3.18 | 3.53 | -0.68 | 0.93 | 3.54 | 1.64 | -3.89 | 1.67 | 3.14 | -1.57 | 2.29 | 2.96 |
| Other Income | 0.84 | 0.29 | 5.14 | 1.58 | 0.02 | 0.68 | 7.54 | 1.55 | 0.79 | 4.18 | -0.43 | 1.72 |
| Interest | 0.41 | 0.47 | 0.4 | 0.96 | 0.49 | 0.58 | 1.3 | 1.04 | 1.26 | 0.92 | 1.78 | 1.67 |
| Depreciation | 1.27 | 1.06 | 1.15 | 0.47 | 1.51 | 0.9 | 0.41 | 0.49 | 0.69 | 0.83 | 0.85 | 0.85 |
| Profit before tax | 1 | 1.46 | 2.15 | 1.33 | 1.74 | 1.4 | 1.62 | 1.73 | 1.48 | 0.92 | 1.28 | 0.52 |
| Tax % | -22 | 30.14 | -0.47 | 6.77 | 8.62 | 48.57 | 71.6 | 20.81 | 31.08 | 38.04 | -21.88 | -98.08 |
| Net Profit | 1.23 | 1.02 | 2.15 | 1.24 | 1.6 | 0.72 | 0.47 | 1.37 | 1.02 | 0.57 | 1.56 | 1.02 |
| EPS in Rs | 0.48 | 0.4 | 0.77 | 0.44 | 0.57 | 0.25 | 0.17 | 0.48 | 0.36 | 0.2 | 0.55 | 0.36 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 349 | 354 | 298 | 348 | 493 | 419 | 396 | 474 | 472 | 415 |
| Expenses | 342 | 347 | 294 | 344 | 481 | 411 | 391 | 471 | 465 | 408 |
| Operating Profit | 8 | 8 | 3 | 5 | 11 | 8 | 4 | 3 | 7 | 7 |
| OPM % | 2.2 | 2.2 | 1.1 | 1.3 | 2.3 | 1.8 | 1.1 | 0.6 | 1.5 | 1.6 |
| Other Income | 3 | 4 | 7 | 7 | 3 | 3 | 7 | 10 | 6 | 6 |
| Interest | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 5 | 6 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 |
| Profit before tax | 8 | 9 | 7 | 8 | 10 | 6 | 5 | 6 | 5 | 4 |
| Tax % | 25 | 27 | 20 | 21 | 35 | 37 | 12 | 34 | 27 | — |
| Net Profit | 6 | 7 | 6 | 7 | 7 | 4 | 5 | 4 | 4 | 4 |
| EPS in Rs | 2.64 | 2.8 | 2.48 | 2.78 | 2.58 | 1.49 | 1.67 | 1.42 | 1.4 | 1.47 |
| Dividend Payout % | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 18 | 23 | 23 | 23 | 23 | 25 | 25 | 28 | 28 | 28 |
| Reserves | 31 | 57 | 63 | 69 | 75 | 88 | 92 | 105 | 110 | 122 |
| Borrowings | 10 | 3 | 16 | 18 | 18 | 14 | 38 | 31 | 35 | 50 |
| Other Liabilities | 83 | 86 | 43 | 84 | 116 | 117 | 136 | 139 | 117 | 97 |
| Total Liabilities | 142 | 170 | 146 | 194 | 233 | 245 | 291 | 303 | 291 | 297 |
| Fixed Assets | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 13 | 16 | 26 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Other Assets | 130 | 157 | 133 | 181 | 218 | 230 | 277 | 289 | 272 | 269 |
| Total Assets | 142 | 170 | 146 | 194 | 233 | 245 | 291 | 303 | 291 | 297 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | -20 | 1 | 3 | 5 | 0 | -1 | -3 | 10 | 10 |
| Cash from Investing Activity | -5 | -1 | -1 | -1 | -3 | -3 | 0 | -2 | -6 | -12 |
| Cash from Financing Activity | 4 | 23 | -2 | -2 | -2 | 2 | 1 | 6 | -4 | 2 |
| Net Cash Flow | -1 | 2 | -3 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Free Cash Flow | -4 | -21 | -1 | 2 | 3 | -2 | -2 | -4 | 5 | -2 |
| CFO/OP | 28 | -232 | 37 | 135 | 154 | 36 | 13 | -37 | 421 | 164 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 75 | 100 | 109 | 118 | 170 | 101 | 165 | 170 | 103 | 100 |
| Inventory Days | 5 | 16 | 23 | 21 | 20 | 11 | 26 | 33 | 36 | 33 |
| Days Payable | 71 | 84 | 40 | 98 | 120 | 86 | 115 | 123 | 81 | 66 |
| Cash Conversion Cycle | 9 | 32 | 92 | 42 | 69 | 26 | 76 | 80 | 58 | 68 |
| Working Capital Days | 34 | 69 | 77 | 99 | 91 | 68 | 89 | 106 | 89 | 90 |
| ROCE % | 22 | 14 | 12 | 8 | 9 | 10 | 6 | 6 | 6 | 6 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 50.04% | 50.04% | 45.28% | 45.28% | 45.44% | 44.8% | 44.8% | 44.8% | 44.8% | 39.06% | 37.71% | 37.71% |
| FIIs | 0% | 3.83% | 3.4% | 3.4% | 2.75% | 2.34% | 2.34% | 1.97% | 1.13% | 3.86% | 4.18% | 4.8% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1.62% | 1.62% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 40.61% | 41.14% | 47.14% | 44.51% | 47.56% | 44.87% | 45.79% | 46.6% | 47.01% | 45.4% | 43.71% | 41.66% |
| Others | 9.35% | 4.99% | 4.18% | 6.82% | 4.25% | 7.99% | 7.07% | 6.63% | 7.06% | 11.69% | 12.78% | 14.2% |
| No. of Shareholders | 16086 | 15269 | 16821 | 16179 | 16676 | 16288 | 16257 | 15796 | 14897 | 14063 | 14188 | 13478 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 4 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 95.26 | Buy |
| EMA (10) | 94.85 | Buy |
| SMA (20) | 88.71 | Buy |
| EMA (20) | 90.96 | Buy |
| SMA (50) | 83.88 | Buy |
| EMA (50) | 86.27 | Buy |
| SMA (100) | 84.57 | Buy |
| EMA (100) | 83.13 | Buy |
| SMA (200) | 77.12 | Buy |
| EMA (200) | 78.12 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 66.95 | Neutral |
| MACD (12,26,9) | 4.44 | Buy |
| Stochastic (14,3,3) | 89.49 | Sell |
| ADX (14) | 28.76 | Buy |
| Williams %R (14) | -8.99 | Sell |
| ATR (14) | 4.17 | High Volatility |
| ROC (12) | 22.46 | Buy |
| Stoch RSI (14) | 79.86 | Neutral |
| UO (7,14,28) | 64.39 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 4 Feb - Board meeting on 11 Feb 2026 to approve unaudited Q3 (Dec 31, 2025) results; trading window closed. | [Board Meeting Intimation for Board Meeting Intimation 4 Feb - Board meeting on 11 Feb 2026 to approve unaudited Q3 (Dec 31, 2025) results; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59bf3ed2-0c13-441d-84a6-0e03804ef353.pdf) |
| 4 Dec 2015 - The Board of the Company have appointed Lt. Gen. Dalbir Singh Sidhu as an independent director on the Board of the Company w.e.f. December 03, … | [Appointment of Director 4 Dec 2015 - The Board of the Company have appointed Lt. Gen. Dalbir Singh Sidhu as an independent director on the Board of the Company w.e.f. December 03, …](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2015/12/41813678_1904_4FE2_A794_A2D9ECE9890B_121609.pdf) |
| 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after FY2026 audited results. | [Closure of Trading Window 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after FY2026 audited results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b7d1e6f5-abc6-429d-b232-aa52876b7661.pdf) |
| 14 Feb - Newspaper Publication of the Unaudited Financial Results | [Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb - Newspaper Publication of the Unaudited Financial Results](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d5f69d2-d920-4f35-a0a7-4bb9896b84b8.pdf) |
| 14 Apr - Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr - Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/732c1778-facc-4bd3-b3dd-c4b016a5eb71.pdf) |
| 12 Feb - Paid ₹5,900 to each exchange for delayed RPT disclosure for half-year ended Sep 30, 2025. | [Board Comments On The Fine Levied By The Exchange 12 Feb - Paid ₹5,900 to each exchange for delayed RPT disclosure for half-year ended Sep 30, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/186a7c15-4f2f-4599-8ba0-2d8b4b1069d0.pdf) |
| 11 Sep - 36th AGM scheduled for 30 September 2026; annual report link shared with unregistered email shareholders. | [Disclosure Under Regulation 30 Of SEBI (LODR)Regulations, 2015 11 Sep - 36th AGM scheduled for 30 September 2026; annual report link shared with unregistered email shareholders.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22a3f025-9093-4624-ad2a-fe8c7f99961e.pdf) |
| 11 Feb - Board approved unaudited Q3 results for quarter ended 31-Dec-2025; limited review and MD/CFO certification. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E 11Th February, 2026. 11 Feb - Board approved unaudited Q3 results for quarter ended 31-Dec-2025; limited review and MD/CFO certification.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5392a051-a7c2-45ca-b211-0f9f7b746438.pdf) |
| 11 Feb - Board approved unaudited financial results for quarter ended 31 Dec 2025; limited review and MD/CFO certifications. | [Unaudited Financial Results For The Quarter Ended 31St December, 2025 11 Feb - Board approved unaudited financial results for quarter ended 31 Dec 2025; limited review and MD/CFO certifications.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d76a41ad-3bef-4a66-be42-1a020a8550a5.pdf) |
| — | [Financial Results, Limited Review Report for December 31, 2015 13 Feb 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/2/1272F072_BFF1_425D_B653_B2C84062C011_151213.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdd409e4-9cf5-4e36-b33a-4526f5b24c13.pdf) |
| 2026-09-08 | [Intimation Of Book Closure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62bb940c-c1d9-43ca-8dce-5c833c61facc.pdf) |
| 2026-09-08 | [Notice Of 36Th Annual General Meeting Of The Company For FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60e17bba-9a14-4e4b-8c9e-f44bf6f1b28f.pdf) |
| 2026-09-08 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=012bf80e-cd00-44ce-88ef-d12e574c59f5.pdf) |
| 2026-09-05 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19b6da42-0a6d-4fbc-af15-7df5ba979a68.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1080fb48-d2b0-4ec9-b19a-e83916ae8f85.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97d48c49-8a3a-4de1-b9c2-7bfeba273560.pdf) |
| 2026-08-07 | [Board Meeting Intimation for Intimation Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53f5e4b9-8a9a-448b-b417-621fd204c963.pdf) |
| 2026-08-06 | [Board Meeting Outcome for Allotment Of Equity Shares Pursuant To Conversion Of Warrants](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=982fbbc6-17aa-4aed-a693-a902d7a66aea.pdf) |
| 2026-07-08 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b168e86c-7cf5-4577-8fbd-09bcd0d3bdd2.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Unaudited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a822c4db-621a-4302-8123-b893b6989e59.pdf) |
| 2026-05-30 | [Audited Standalone Financial Results Of The Company For The Fourth Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=300b98ef-4eeb-4c6a-ba2a-adce54947dd3.pdf) |
| 2026-02-11 | [Unaudited Financial Results For The Quarter Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d76a41ad-3bef-4a66-be42-1a020a8550a5.pdf) |
| 2025-11-13 | [Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d99ee85b-8f14-4a22-a795-d37a95a179ad.pdf) |
| 2025-08-13 | [Unaudited Financial Results For The Quarter Ended 30Th June 2025 Along With The Limited Review Report MD/CFO Certification.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ecca3b3-c285-4418-a86c-f4b147059f42.pdf) |
| 2025-05-30 | [Reg. 33 - Audited Financial Results For The Quarter & Financial Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b3c9058-b51d-4da6-b00a-370478ddb2c7.pdf) |
| 2025-02-14 | [Unaudited Financial Result For December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13f5cac2-0ed8-41d6-b995-4557bf963f1c.pdf) |
| 2024-11-14 | [Financial Result For September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4474727d-bd49-4bee-b731-204dc5f2862b.pdf) |
| 2024-08-14 | [Unaudited Financial Result For June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6abdc7c-0f31-4567-919a-a4a6b5bf6c59.pdf) |
| 2024-05-30 | [Audited Financial Result For March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4d54e25-b91a-4ddc-a7be-0b0fd39cd62f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2010 from nse](https://archives.nseindia.com/annual_reports/AR_SIMBHSUGAR_2009_2010_02022011192656.zip) |
| from nse | [Financial Year 2009 from nse](https://archives.nseindia.com/annual_reports/AR_SIMBHSUGAR_2008_2009_18082010121500.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92f6cf66-a1e9-487e-a5f9-9ad0086c8122.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4af87262-68b6-4892-bbae-d107113e83e1.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f27b4b0d-9085-40a0-9ee7-a699a5dd2df8.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524412/75591524412.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524412/69597524412.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524412/67854524412_09_12_20.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524412/5244120319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524412/5244120318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:32:15.633Z.